(R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use

Details for Australian Patent Application No. 2012211459 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Perez, Julio; Doshan, Harold D.

Agent Davies Collison Cave

Pub. Number AU-A-2012211459

Parent 2006249911

Filing date 9 August 2012

Wipo publication date 30 August 2012

International Classifications

C07D 489/08 Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine

A61P 1/10 Drugs for disorders of the alimentary tract or the digestive system

A61P 25/04 Drugs for disorders of the nervous system

Event Publications

23 August 2012 Complete Application Filed

30 August 2012 Application Open to Public Inspection

  Published as AU-A-2012211459

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012211460-Balsalazide formulations and manufacture and use thereof

2012211458-Amine derivative having NPY Y5 receptor antagonist activity